RESUMO
PURPOSE: To explore experiences of sheltering in place and accessing treatment during the initial stages of the COVID-19 pandemic among survivors with cancer receiving tyrosine kinase inhibitor (TKI) therapy. METHODS: Participants from two pilot studies evaluating TKI therapy use in the Southeastern United States during the start of the COVID-19 pandemic (March 2020) were interviewed. Identical interview guides were used across both studies to assess participants' experiences accessing cancer treatment, sheltering in place, and coping during the COVID-19 pandemic. Digitally recorded sessions were transcribed professionally and checked for accuracy. Descriptive statistics were used to summarize participant sociodemographics, and a six-step thematic approach was used to analyze interview data and identify salient themes. Dedoose qualitative research software was used to manage and organize qualitative codes, themes, and memos. RESULTS: Participants (n = 15) ranged from 43 to 84 years of age, and were mostly female (53.3%), married (60%), and survivors with hematologic malignancies (86.7%). The research team identified five salient themes: Participants followed pandemic guidelines, Variable impact on well-being, Common feelings of fear, anxiety and anger, No barriers to accessing therapy and medical care, and Faith and God as powerful forces for coping. CONCLUSIONS: The conclusions of the study provide several implications for survivorship programs or clinics for supporting survivors who are taking chronic TKI therapy during COVID-19, including enhancement of current psychosocial support efforts for cancer survivors or development of new programs tailored to the unique needs of a survivor during a pandemic, such as focused coping strategies, modified physical activity programs, family/professional role changes, and access to safe public spaces.
Assuntos
COVID-19 , Sobreviventes de Câncer , Neoplasias , Humanos , Feminino , Masculino , Sobreviventes de Câncer/psicologia , COVID-19/epidemiologia , Pandemias , Sobreviventes/psicologia , Adaptação Psicológica , Neoplasias/epidemiologia , Neoplasias/terapiaRESUMO
BACKGROUND: The histological differential diagnosis of Crohn's disease and intestinal tuberculosis can be very challenging, as both are chronic granulomatous disorders with overlapping histological features. AIM: To evaluate selected clinical and histological parameters in colonic biopsy specimens for their ability to discriminate between Crohn's disease and intestinal tuberculosis. METHODS: 25 patients with Crohn's disease and 18 patients with intestinal tuberculosis were selected for this study on the basis of established clinical, radiological and histological criteria. Clinical data and selected histological parameters in colonoscopic biopsy specimens were assessed retrospectively. A total of 103 and 41 biopsy sites were evaluated in patients with Crohn's disease and intestinal tuberculosis, respectively. RESULTS: Clinical parameters helpful in differentiating intestinal tuberculosis from Crohn's disease included chest radiographic features of tuberculosis (56% v 0%), perianal fistulae (0% v 40%) and extraintestinal manifestations of Crohn's disease (0% v 40%). Histopathological features that seemed to reliably differentiate between intestinal tuberculosis and Crohn's disease included confluent granulomas, > or =10 granulomas per biopsy site and caseous necrosis (in biopsy samples of 50%, 33% and 22% of patients with intestinal tuberculosis, respectively, v 0% of patients with Crohn's disease). Features that were observed more often in patients with intestinal tuberculosis than in those with Crohn's disease included granulomas exceeding 0.05 mm(2) (67% v 8%), ulcers lined by conglomerate epithelioid histiocytes (61% v 8%) and disproportionate submucosal inflammation (67% v 10%). CONCLUSION: Clinical features and selected histological parameters in colonoscopic biopsy specimens can help in differentiating between Crohn's disease and intestinal tuberculosis.
Assuntos
Doença de Crohn/patologia , Tuberculose Gastrointestinal/patologia , Adolescente , Adulto , Biópsia , Colo/patologia , Colonoscopia , Diagnóstico Diferencial , Feminino , Granuloma/patologia , Humanos , Mucosa Intestinal/patologia , Masculino , Pessoa de Meia-Idade , Estudos RetrospectivosRESUMO
In this work, we characterize genes in Mycobacterium tuberculosis that are regulated by IdeR (iron-dependent regulator), an iron-responsive DNA-binding protein of the DtxR family that has been shown to regulate iron acquisition in Mycobacterium smegmatis. To identify some of the genes that constitute the IdeR regulon, we searched the M. tuberculosis genome for promoter regions containing the consensus IdeR/DxR binding sequence. Genes preceded by IdeR boxes included a set encoding proteins necessary for iron acquisition, such as the biosynthesis of siderophores (mbtA, mbtB, mbtI), aromatic amino acids (pheA, hisE, hisB-like) and others annotated to be involved in the synthesis of iron-storage proteins (bfrA, bfrB). Some putative IdeR-regulated genes identified in this search encoded proteins predicted to be engaged in the biosynthesis of lipopolysaccharide (LPS)-like molecules (rv3402c), lipids (acpP) and peptidoglycan (murB). We analysed four promoter regions containing putative IdeR boxes, mbtA-mbtB, mbI, rv3402c and bfrA-bfd, for interaction with IdeR and for iron-dependent expression. Gel retardation experiments and DNase footprinting analyses with purified IdeR showed that IdeR binds to these IdeR boxes in vitro. Analysis of the promoters by primer extension indicated that the IdeR boxes are located near the -10 position of each promoter, suggesting that IdeR acts as a transcriptional repressor by blocking RNA polymerase binding. Using quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) coupled to molecular beacons, we showed that mRNA levels of mbtA, mbtB, mbtI, rv3402c and bfd are induced 14- to 49-fold in cultures of M. tuberculosis starved for iron, whereas mRNA levels of bfrA decreased about threefold. We present evidence that IdeR not only acts as a transcriptional repressor but also functions as an activator of bfrA. Three of the IdeR- and iron-repressed genes, mbtB, mbtI and rv3402c, were induced during M. tuberculosis infection of human THP-1 macrophages.
Assuntos
Proteínas de Bactérias/metabolismo , Regulação Bacteriana da Expressão Gênica , Ferro/metabolismo , Macrófagos/microbiologia , Mycobacterium tuberculosis/patogenicidade , Proteínas Repressoras , Proteínas de Bactérias/genética , Sequência de Bases , Humanos , Dados de Sequência Molecular , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/crescimento & desenvolvimento , Mycobacterium tuberculosis/metabolismo , Transcrição Gênica , Tuberculose/microbiologia , VirulênciaAssuntos
Biópsia por Agulha , Carcinoma Broncogênico/patologia , Carcinoma Pulmonar de Células não Pequenas/patologia , Neoplasias Pulmonares/patologia , Biópsia por Agulha/efeitos adversos , Contraindicações , Diagnóstico Diferencial , Humanos , Pulmão/patologia , Neoplasias Pulmonares/secundário , Linfonodos/patologia , Metástase Linfática , Estadiamento de Neoplasias , Valor Preditivo dos TestesAssuntos
Neoplasias dos Ductos Biliares/terapia , Colestase/terapia , Drenagem/instrumentação , Neoplasias dos Ductos Biliares/complicações , Neoplasias dos Ductos Biliares/diagnóstico , Cateteres de Demora , Colestase/diagnóstico , Colestase/etiologia , Diagnóstico por Imagem , Humanos , Cuidados Paliativos , Stents , Resultado do TratamentoRESUMO
OBJECTIVE: To determine the change in health-related quality of life associated with uterine fibroid embolization (UFE). MATERIALS AND METHODS: A health-related quality-of-life questionnaire was administered before and after therapy. The questionnaire contained validated scales from the Medical Outcomes Study, with additional domains and symptom items specific to fibroids. Patients treated with UFE for symptomatic uterine leiomyomata completed a health-related quality of life questionnaire before therapy. A follow-up quality of life questionnaire and an additional brief questionnaire to assess symptom improvement were completed 3 and 6 months postprocedure. Confirmatory reliability and validity testing was also conducted. Mean scores for each scale on the quality of life questionnaire were calculated and change scores were computed. RESULTS: Fifty women were enrolled in the study and completed the baseline assessment. Health-related quality of life scores improved in all instances at follow-up. Mean change scores were statistically significant for all domains between baseline and month 3 (P < .01) and between baseline and month 6 (P < .05) except backache (P = .12). CONCLUSION: Patients undergoing UFE report significant improvements in health-related quality of life and fibroid-specific symptoms. These findings suggest that the measurement of health-related quality of life may be an effective means of comparing the outcome of UFE with other fibroid therapies.
Assuntos
Embolização Terapêutica , Leiomioma/terapia , Qualidade de Vida , Neoplasias Uterinas/terapia , Adulto , Feminino , Humanos , Leiomioma/diagnóstico , Pessoa de Meia-Idade , Satisfação do Paciente , Reprodutibilidade dos Testes , Estudos Retrospectivos , Inquéritos e Questionários , Neoplasias Uterinas/diagnósticoRESUMO
PURPOSE: To compare the success of percutaneous varicocele embolization to surgical ligation with regard to changes in semen characteristics and pregnancy outcome. MATERIALS AND METHODS: Infertility records from 346 men who underwent correction of their varicocele for infertility (surgical ligation 149; embolization 197) were reviewed retrospectively. Preprocedural and postprocedural semen analyses and pregnancy outcomes were obtained with use of chart and telephone follow-up. RESULTS: In men who successfully impregnated their partners, there were significant improvements in sperm density, percent total improvement, motility, and progression. Postprocedural (embolization vs surgery) percentage increases in seminal parameters were density, 156.8% versus 138.5%; total, 168.8% versus 157.91%; and motility, 2.7% versus 3.2%. The percent of individuals who had a change in sperm progression was 31% versus 41%. There was no statistical difference between the techniques based on t tests. The pregnancy rates were similar for the two groups, 39% and 34% for embolization and surgery, respectively. CONCLUSION: There is no significant statistical difference in seminal values or pregnancy outcome between the two techniques.
Assuntos
Embolização Terapêutica , Infertilidade Masculina/etiologia , Contagem de Espermatozoides , Motilidade dos Espermatozoides , Varicocele/terapia , Adulto , Embolização Terapêutica/efeitos adversos , Embolização Terapêutica/métodos , Feminino , Humanos , Ligadura , Masculino , Pessoa de Meia-Idade , Gravidez , Punções , Estudos Retrospectivos , Varicocele/complicaçõesRESUMO
PURPOSE: The authors prospectively compared the nature and incidence of hepatic arterial injuries resulting from creation of a transjugular intrahepatic portosystemic shunt (TIPS) with large- and small-gauge needle systems. PATIENTS AND METHODS: Fifty patients underwent hepatic and superior mesenteric angiography immediately before and after shunt creation. A sheathed 16-gauge needle system was used to locate and puncture the portal vein in 24 patients. A 21-gauge needle system was used in 26 patients. RESULTS: Shunts were successfully created in all patients. Three inadvertent hepatic arterial punctures were recognized during shunt placement, two with the small needle and one with the large needle system. No hepatic arterial lesions were detected in any patient. Two incidental hepatomas were identified at angiography. CONCLUSION: TIPS-related hepatic arterial injuries are rare. In this series, large and small needle systems were indistinguishable with respect to this complication.
Assuntos
Artéria Hepática/lesões , Agulhas/efeitos adversos , Derivação Portossistêmica Cirúrgica/efeitos adversos , Adulto , Idoso , Angiografia Digital , Carcinoma Hepatocelular/diagnóstico por imagem , Desenho de Equipamento , Feminino , Artéria Hepática/diagnóstico por imagem , Humanos , Incidência , Veias Jugulares , Cirrose Hepática/cirurgia , Cirrose Hepática Alcoólica/cirurgia , Neoplasias Hepáticas/diagnóstico por imagem , Masculino , Artéria Mesentérica Superior/diagnóstico por imagem , Pessoa de Meia-Idade , Veia Porta , Derivação Portossistêmica Cirúrgica/instrumentação , Estudos Prospectivos , Punções/instrumentação , Propriedades de SuperfícieRESUMO
PURPOSE: The authors present their experience with 494 hepatic chemoembolization (HCE) procedures in 236 patients with administration of a mixture of cross-linked collagen and chemotherapeutic agents. The prevalence of infectious complications was compared in patients who did and did not receive prophylactic administration of antibiotics as part of the HCE procedure. PATIENTS AND METHODS: Fourteen HCE procedures in nine patients were performed without prophylactic antibiotics (PA). These patients underwent embolization with cross-linked collagen alone or with low-dose cisplatinum. All of the remaining 480 procedures in 227 patients were performed with PA. RESULTS: One of the nine patients (11%) who did not receive PA experienced fatal sepsis within 24 hours of HCE. Of the 227 patients who did receive antibiotics, six (2.6%) developed hepatic abscess and no fatal sepsis was encountered. CONCLUSION: Use of PA decreases the prevalence of infectious complications following HCE.
Assuntos
Antibacterianos/uso terapêutico , Antineoplásicos/administração & dosagem , Quimioembolização Terapêutica/efeitos adversos , Colágeno/administração & dosagem , Abscesso Hepático/epidemiologia , Adulto , Idoso , Feminino , Humanos , Abscesso Hepático/microbiologia , Abscesso Hepático/prevenção & controle , Neoplasias Hepáticas/terapia , Masculino , Pessoa de Meia-Idade , Pré-Medicação , Prevalência , Estudos RetrospectivosRESUMO
Reconstructive vascular surgery is the last resort for limb salvage in patients with vascular insufficiency. Planning the sites of arterial bypass grafts depends on an exact knowledge of the angiographic anatomy. Currently, conventional contrast angiography is the primary preoperative study for surgical planning. Recently, magnetic resonance (MR) arteriography has been shown to be an accurate technique for the evaluation of slow arterial flow in the lower extremities. The purpose of this review will be to show how MR arteriography can be used as both an adjunct to and in some cases instead of conventional angiography for the preoperative assessment of lower-extremity vascular reconstruction. The derivation of common artifacts, the many pitfalls of interpretation, and the evaluation of peripheral arterial occlusion and percentage stenosis will be discussed. MR arteriography of the lower extremities is an important advance for the noninvasive evaluation of disease of the peripheral vasculature.
Assuntos
Perna (Membro)/cirurgia , Imageamento por Ressonância Magnética , Pelve/cirurgia , Procedimentos Cirúrgicos Vasculares/métodos , Algoritmos , Artefatos , Humanos , Processamento de Imagem Assistida por Computador , Perna (Membro)/patologia , Pelve/patologiaRESUMO
After successful removal of a primary tumor, the exclusive or dominant site of metastatic spread is often the liver. Existing palliative treatments, particularly chemotherapy, have low success rates. Fortuitous physiologic circumstances allow the use of regional treatments, such as hepatic artery infusion therapy, for both primary and secondary malignant tumors in the liver. Despite encouraging results in early uncontrolled trials, subsequent randomized studies have failed to show survival benefit with regional infusion therapy via surgically implanted pumps in patients who have colorectal metastases, the most common tumor studied. Dissatisfaction with current treatments has led to a host of novel therapies, including embolization of liver tumors and the combined infusion of embolic particles and chemotherapeutic agents (i.e., chemoembolization).
Assuntos
Antineoplásicos/administração & dosagem , Carcinoma Hepatocelular/terapia , Quimioembolização Terapêutica , Neoplasias Colorretais/patologia , Embolização Terapêutica , Neoplasias Hepáticas/secundário , Neoplasias Hepáticas/terapia , Apudoma/terapia , Artéria Hepática , Humanos , Bombas de Infusão Implantáveis , Infusões Intra-Arteriais , Veia PortaRESUMO
PURPOSE: Nine patients with unresectable hepatic malignancy and portal vein thrombosis underwent hepatic chemoembolization. PATIENTS AND METHODS: Six patients had primary malignancies (hepatocellular carcinoma in five, hepatoblastoma in one), and three had metastatic tumor (adenocarcinoma of the colon in two, glucagonoma in one). Chemoembolization was performed with 10 mg/mL of cross-linked collagen, 10 mg/mL of mitomycin, 3 mg/mL of doxorubicin, and 3 mg/mL of cisplatin. Each patient was treated until flow in the hepatic artery ceased completely. RESULTS: All treatments were technically successful. Eight patients responded to treatment, including two long-term survivors (> 2 years). One patient died 31 days after treatment of progressive hepatic malignancy and atherosclerotic disease. No patient developed hepatic infarction or insufficiency as a result of treatment. Follow-up ranged from 1 to 26 months (mean, 13 months). CONCLUSION: Portal vein thrombosis should not be considered an absolute contraindication to hepatic chemoembolization. Hepatic chemoembolization can be performed safely in the presence of adequate collateral circulation.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Quimioembolização Terapêutica , Neoplasias Hepáticas/terapia , Veia Porta , Trombose/complicações , Adulto , Quimioembolização Terapêutica/efeitos adversos , Quimioembolização Terapêutica/métodos , Pré-Escolar , Colágeno/administração & dosagem , Contraindicações , Feminino , Artéria Hepática , Humanos , Neoplasias Hepáticas/complicações , Neoplasias Hepáticas/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , RadiografiaRESUMO
An arteriovenous fistula between the renal artery and vein is a rare complication of nephrectomy. We report the first case of direct inferior vena cava to renal artery fistula after nephrectomy. In addition, this was the first use of the Amplatz "spider," a vascular obstructing device used to trap coils during transcatheter embolization of a high-flow fistula. The patient's fistula was embolized successfully, with immediate improvement of symptoms and without pulmonary embolization.
Assuntos
Aorta Abdominal , Fístula Arteriovenosa/terapia , Embolização Terapêutica/métodos , Nefrectomia , Complicações Pós-Operatórias/terapia , Artéria Renal , Veia Cava Inferior , Idoso , Aorta Abdominal/diagnóstico por imagem , Fístula Arteriovenosa/diagnóstico por imagem , Fístula Arteriovenosa/etiologia , Embolização Terapêutica/instrumentação , Desenho de Equipamento , Feminino , Humanos , Complicações Pós-Operatórias/diagnóstico por imagem , Complicações Pós-Operatórias/etiologia , Radiografia , Artéria Renal/diagnóstico por imagem , Veia Cava Inferior/diagnóstico por imagemRESUMO
Tunis and colleagues attempted to assess the effect of peripheral angioplasty in a large population with descriptive epidemiologic methods. Their study suffered from a vague statement of purpose, inappropriate and inadequate outcome measures, undetermined differences in prevalence of peripheral vascular disease and prevalence of risk factors for bypass/amputation in 1989 versus 1979, no differentiation between levels of amputation or between primary and secondary amputation, lack of a unique ICD-9-CM code indicating angioplasty for peripheral vascular disease of the lower extremities, lack of unique patient identifiers, a mistaken perception of the adoption of angioplasty as "widespread" in Maryland, and the assumption of uniform coding accuracy throughout the period of study. We conclude that the study design of Tunis et al was inadequate to determine the beneficial effects of angioplasty or bypass surgery in the treatment of peripheral vascular disease. Moreover, the conclusion by Coffman (2) that "invasive procedures are indicated only for the severely ischemic limb" is completely unsupported by the study data. Physicians should not attempt to apply the results of the study by Tunis et al to individual case situations. It should be further appreciated that the study findings do not provide an adequate basis for policy-making decisions. It is clear that important clinical questions concerning the roles of angioplasty, bypass, and amputation should be answered with more definitive studies.
Assuntos
Amputação Cirúrgica/estatística & dados numéricos , Angioplastia com Balão/estatística & dados numéricos , Derivação Arteriovenosa Cirúrgica/estatística & dados numéricos , Doenças Vasculares Periféricas/terapia , Algoritmos , Humanos , Maryland/epidemiologia , Doenças Vasculares Periféricas/epidemiologia , Prevalência , Reprodutibilidade dos Testes , Projetos de Pesquisa , Estudos RetrospectivosRESUMO
One hundred fifteen patients with a unilateral knee dislocation underwent arteriography to examine the popliteal artery. The incidence of popliteal artery injury was 23% (27 patients). Clinically, 29 (25%) of the 115 patients had an abnormal ipsilateral pedal pulse and 23 (79%) of these 29 patients had an arteriographically identified popliteal artery injury. Twenty-two arteries were surgically repaired and one was treated without surgery. Eight-six patients had normal pulses; the arteriogram showed no abnormalities in 77, demonstrated spasm in five, and revealed an intimal flap in four. All 86 patients were treated without surgery and had no delayed vascular complications. This demonstrates that the vascular examination is an accurate predictor of major popliteal artery injury following knee dislocation. Patients with an abnormal pedal pulse warrant arteriography due to a high incidence (79%) of popliteal artery injury. Patients with normal pulses may be monitored by clinical examination only. Popliteal artery injuries in this group are minor and rarely require intervention.
Assuntos
Luxações Articulares/diagnóstico por imagem , Traumatismos do Joelho/diagnóstico por imagem , Artéria Poplítea/diagnóstico por imagem , Artéria Poplítea/lesões , Adolescente , Adulto , Idoso , Aneurisma/diagnóstico por imagem , Angiografia , Arteriopatias Oclusivas/diagnóstico por imagem , Constrição Patológica/diagnóstico por imagem , Feminino , Seguimentos , Pé/irrigação sanguínea , Humanos , Luxações Articulares/classificação , Traumatismos do Joelho/classificação , Masculino , Pessoa de Meia-Idade , Artéria Poplítea/cirurgia , Pulso Arterial , Resultado do Tratamento , Vasoconstrição , Ferimentos não Penetrantes/diagnóstico por imagemRESUMO
Preoperative therapy has been tested as part of limb salvage therapy for localized bone and soft tissue sarcoma of the extremities. The activity of cisplatin (CDDP) by intraarterial (IA) infusion was evaluated in 40 cases of which 36 were evaluable for response. All patients had high-grade sarcomas. All but 3 patients received 3 or 4 courses (24 patients received 4 courses) of CDDP at a dosage of 120 to 150 mg/m2 given over 6 hours every 2 weeks by IA infusion. Patients younger than 18 years of age received the higher dose of CDDP. Treatment was well tolerated with combination antiemetics. One patient experienced severe hearing loss with the first cycle of the higher CDDP dose. Pathologic evaluation of resected osteosarcoma showed a favorable response (90% or greater necrosis) in 8 of 20 evaluable cases and in 3 of 4 patients with malignant fibrous histiocytoma (MFH) of bone (without osteoid). In soft tissue sarcomas, minimal (50% to 89%) necrosis was seen in two of nine cases and none had 90% or greater necrosis. Patients received postoperative chemotherapy based on pathologic response, but the value of this postoperative adjuvant therapy requires further follow-up and is uncertain in this small study. IA CDDP can often cause significant tumor necrosis in patients with bone sarcomas, whereas soft tissue sarcomas are less sensitive to this therapy.
Assuntos
Neoplasias Ósseas/terapia , Cisplatino/uso terapêutico , Extremidades/cirurgia , Sarcoma/terapia , Neoplasias de Tecidos Moles/terapia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias Ósseas/mortalidade , Neoplasias Ósseas/patologia , Criança , Cisplatino/efeitos adversos , Terapia Combinada , Avaliação de Medicamentos , Humanos , Infusões Intra-Arteriais , Pessoa de Meia-Idade , Necrose , Sarcoma/mortalidade , Sarcoma/patologia , Neoplasias de Tecidos Moles/mortalidade , Neoplasias de Tecidos Moles/patologia , Taxa de SobrevidaRESUMO
The authors performed 13 transcatheter embolizations (TCEs) within the axilla and shoulder in nine patients with major trauma to one or more vessels in these regions. Indications for TCE included active hemorrhage, pseudoaneurysms, arteriovenous fistulas (AVFs) caused by penetrating trauma, and a postsurgical AVF. Embolizations were performed within branches of the subclavian, axillary, and brachial arteries in nine male patients aged 20-38 years. All procedures were performed with use of either Gianturco coils or Hilal wires, with or without gelatin sponge pledgets or autologous clot. Nine of 11 procedures in eight patients resulted in successful treatment of active bleeding, pseudoaneurysms, and AVFs, thus enabling avoidance of surgery. After two embolizations in the ninth patient, TCE failed to occlude an AVF, necessitating surgical treatment. Only one complication (asymptomatic pulmonary embolization with Gianturco coils) was encountered in this series. No neurologic sequelae occurred. The authors' experience demonstrates the safety and efficacy of TCE in the nonsurgical management of axillary and shoulder hemorrhage and vascular injuries secondary to penetrating trauma and surgical complications.